Earnings call transcript: Ingersoll Rand Q2 2025 meets EPS forecast, stock falls

Ingersoll Rand reported its Q2 2025 earnings, meeting the expected earnings per share (EPS) of $0.80, while revenue slightly exceeded forecasts, reaching $1.89 billion against an expected $1.85 billion. Trading at a P/E ratio of 41.7x and a notably high PEG ratio of 83.4x, InvestingPro analysis suggests the stock is currently trading near its Fair Value. Despite these results, the company’s stock fell by 1.32% in after-hours trading and continued to decline by 6.65% in pre-market activity, reflecting investor concerns over future growth prospects.

Key Takeaways

• Ingersoll Rand’s Q2 EPS of $0.80 met expectations, with revenue slightly surpassing forecasts.
• The company’s stock declined by 6.65% in pre-market trading following the earnings release.
• Ingersoll Rand raised its full-year guidance for revenue, adjusted EBITDA, and adjusted EPS.
• The company completed 11 M&A transactions, acquiring $200 million in annualized revenue.
• The total backlog increased by 16% since 2024, signaling strong future demand.

Company Performance

Ingersoll Rand demonstrated robust performance in Q2 2025, maintaining its adjusted EPS at $0.80, which represents an 18% increase on a two-year stack. The company reported an adjusted EBITDA of $590 million, with a margin of 27%. InvestingPro data shows strong financial health with an overall score of 2.78 (GOOD), supported by a current ratio of 2.38 and moderate debt levels. Despite a decline in free cash flow to $210 million year-over-year, the company maintained strong liquidity of $3.9 billion and improved its leverage ratio by 0.3 turns to 1.7.

Financial Highlights

• Revenue: $1.89 billion, slightly above the $1.85 billion forecast.
• Earnings per share: $0.80, meeting expectations.
• Adjusted EBITDA: $590 million, with a 27% margin.
• Free cash flow: $210 million, down year-over-year.
• Total liquidity: $3.9 billion.

Earnings vs. Forecast

Ingersoll Rand’s Q2 2025 EPS of $0.80 met the forecast, while revenue of $1.89 billion exceeded expectations by 2.16%. The alignment with EPS forecasts suggests stable performance, though the revenue surprise indicates stronger-than-anticipated sales.

Market Reaction

Despite meeting EPS expectations and surpassing revenue forecasts, Ingersoll Rand’s stock fell by 1.32% post-earnings and further declined by 6.65% in pre-market trading. According to InvestingPro, analysts maintain a bullish outlook with a consensus recommendation of 1.94 (Buy), though 6 analysts have recently revised their earnings expectations downward. The stock’s performance reflects investor apprehension about the company’s future growth prospects, despite its strong backlog and raised guidance. InvestingPro subscribers have access to 8 additional exclusive insights about Ingersoll Rand’s valuation and growth potential through the comprehensive Pro Research Report.

Outlook & Guidance

Ingersoll Rand raised its full-year guidance for revenue, adjusted EBITDA, and adjusted EPS, reflecting confidence in its strategic initiatives and market position. The company anticipates a slight improvement in organic volume in the second half of the year, with expected pricing adjustments of 3.5-4%. Capital expenditure is projected to be around 2% of revenue.

Executive Commentary

CEO Vicente Reynal emphasized the company’s focus on agility and leveraging its IRX framework in a dynamic environment, stating, "We continue to focus on controlling what we can control." CFO Vic Kinney highlighted the disciplined approach to mergers and acquisitions, which contributed to the company’s growth.

Risks and Challenges

• Tariff uncertainties could impact order decisions and market dynamics.
• Supply chain disruptions remain a potential risk for operational efficiency.
• Market saturation and competition may limit growth opportunities.
• Macroeconomic pressures, such as interest rate changes, could affect financial performance.
• The impairment of specific business units like ILC Dover poses challenges.

Q&A

During the earnings call, analysts inquired about the impact of tariff uncertainties on order decisions and the company’s strategy in navigating these challenges. The management explained the impairment of the ILC Dover and High Pressure Solutions businesses and emphasized the resilience of the China market, where positive organic order growth was observed.

Full transcript - Ingersoll Rand Inc (IR) Q2 2025:

Conference Operator: Hello, and welcome to the Ingersoll Rand Second Quarter twenty twenty five Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question and answer session. I would now like to turn the conference over to Matthew Ford, Vice President, Investor Relations. You may begin.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Thank you, and welcome to the Ingersoll Rand twenty twenty five second quarter earnings call. I’m Matthew Ford, Vice President of Investor Relations. And joining me this morning are Vicente Reynal, Chairman and CEO and Vic Kinney, Chief Financial Officer. We issued our earnings release and presentation yesterday afternoon, and we will reference these during the call. Both are available on the Investor Relations section of our website.

In addition, a replay of this conference call will be available later today. Before we start, I want to remind everyone that certain statements on this call are forward looking in nature and are subject to the risks and uncertainties discussed in our previous SEC filings, which

Vicente Reynal, Chairman and CEO, Ingersoll Rand: you

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: should read in conjunction with the information provided on this call. Please review the forward looking statements on Slide two for more details. In addition, in today’s remarks, we will refer to certain non GAAP financial measures. You can find a reconciliation of these measures to the most comparable measure calculated and presented in accordance with GAAP in our slide presentation and in our earnings release, both of which are available on the Investor Relations section of our website. On today’s call, we will review our company and segment financial highlights and provide an update to our full year 2025 guidance.

For today’s Q and A session, we ask that each caller keep to one question and one follow-up to allow for time for other participants. At this time, I will turn the call over to Vicente.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Thanks, Matthew, and good morning to all. Beginning on Slide three, with our strong start in the first half of the year, we’re raising our full year guidance on revenue, adjusted EBITDA and adjusted EPS. With first half organic order growth of low single digits, a book to bill of 1.06 times and a total backlog increasing by 16% since the 2024, we remain confident in our full year outlook. We continue to focus on controlling what we can control, staying agile and leveraging IRX in what remains a very dynamic environment. On Slide four, we continue to lead in sustainability and achieve strong financial performance while supporting the planet, our community and employees.

Our 2024 sustainability report outlines our commitment to innovation that benefits customers, improves efficiency, drives new opportunities, and delivers consistent shareholder value. For the third consecutive year, we were ranked number one in North America and globally in our industry on the Dow Jones best in class indices. And we placed in the top 1% of the corporate sustainability assessment. Additionally, Ingersoll Rand earned a spot on CDP’s A List for the second year in a row, recognizing our global environmental leadership and transparency. We strongly believe that a combination of our ownership mindset and creating a great place to work is a true catalyst for long term performance.

And that long term performance to date has driven approximately $600,000,000 of value creation for our team through our employee equity grants since the Gardner Denver IPO. Moving to the next page, our value creation flywheel remains a central driver of our success. And our company’s culture of an ownership mindset underpinned by IRX delivers long term value creation and strong cash flow. We continue to leverage this cash flow through our capital allocation strategy, prioritizing M and A and focusing on high return investment. Since our last earnings call, we have announced two additional transactions adding approximately $90,000,000 in annualized inorganic revenue.

We have now closed on 11 transactions this year, totaling over $200,000,000 in annualized revenue at a 9.5 times pre synergy EBITDA multiple. These results are a great start towards achieving our annual target of adding 400 to 500 basis points in inorganic revenue acquired. And on top of that, we have another eight deals under current LOI. Over the past five years, we have completed 70 transactions with approximately 90% of those deals being sole sourced, largely coming from family owned companies. Through each transaction, we continue to improve upon the process we have built for this incredible M and A flywheel, but we also stay humble and learn more with every transaction.

I also like to point out that since the closing of ILC Dover just over a year ago, we have continued to compound value for our shareholders by deploying approximately $650,000,000 to acquisitions. This capital was deployed across 20 acquisitions adding over $300,000,000 in annualized revenue at a 9.5 times pre synergy adjusted EBITDA purchase multiple. These acquisitions have been spread out across all of our growth platforms, adding attractive technologies in attractive end markets, continuing to turn our value creation flywheel, all while deleveraging our balance sheet by 0.3 times creating room for future M and A. Moving into our recent acquisitions, Lead Fluid is the first step towards building our new life science platform. We’re excited about this acquisition as it brings two things.

First, advanced peristaltic pump technology, which addresses a previous gap in our comprehensive pump portfolio. And second, it helps broaden our geographical reach as our Life Science platform is currently underpenetrated in Asia. It is important to note that we have another bolt on deal under LOI, which will continue to broaden our Life Science platform and we expect that transaction to close within the next few days. Another acquisition to highlight is Thermo Mechanica Industrial Compressors, which is a core bolt on for our compressor business. Both lead fluid and Thermo Mechanica were completed at a low double digit pre synergy adjusted EBITDA purchase multiple, and we expect these transactions to meet a mid teens ROIC by the end of the third year.

I will now turn the presentation over to Vic to provide an update on our Q2 financial performance.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Thanks, Asante. Starting on slide six, orders continued their strong start up 8% year over year with the book to bill of 1.03 times. Sequentially from Q1 to Q2, we saw a 3% order growth as well as a mid single digit increase in backlog. As Asante mentioned, compared to the 2024, our backlog is up mid teens. We are pleased with the first half organic order performance, which is up low single digits.

Aftermarket revenue finished at 37% of total revenue which is up 100 basis points year over year. And the second quarter finished largely in line with expectations for revenue, adjusted EBITDA and adjusted EPS despite the dynamic macro environment which demonstrates our ability to continue to execute well. The company delivered second quarter adjusted EBITDA of $5.00 $9,000,000 with an adjusted EBITDA margin of 27%. The year over year decline in adjusted EBITDA margin was driven primarily by the flow through on organic volume declines, as expected the dilutive impact from recently acquired businesses, the dilutive impact of tariff pricing matching tariff costs one for one and continued targeted investments to drive organic growth. Corporate costs came in at $35,000,000 for the quarter.

Our Q2 adjusted tax rate was 23.6% and adjusted earnings per share was $0.80 for the quarter, which on a two year stack is up 18%. In the second quarter, we recorded both a non cash goodwill and asset impairment. These adjustments have no effect on our adjusted earnings or the underlying operational performance of the business. We provided detailed information in the 10 Q, which was filed yesterday, but I’ll take a moment to provide some commentary. The impairments were driven by two major components: the High Pressure Solutions business and ILC Dover.

Starting with the High Pressure Solutions business, we wrote down the minority stake we retained when we sold off the business. This write down was due to changes in the revised long term outlook driven by the upstream oil and gas market. And specific to ILC Dover, first, we had a change in the long term outlook for our Aerospace and Defense business due to reduced expectations for business with a certain customer that resulted in an impairment. Second, while our long term forecast for the BioPharma business remains robust, we did record an impairment. This impairment was driven primarily by market based inputs such as an increase in the discount rate and contraction of peer market multiples.

And finally, to a lesser extent, we recorded an impairment related to the ILC Dover trade name due largely to the above stated factors. Given the ILC Dover impairments, I would like to comment on our disciplined approach to M and A. We have a holistic approach that includes comprehensive diligence appropriate for the transaction as well as negotiated representations and warranties. In the ILC Dover transaction, these reps and warranties were backed up by insurance and we have filed a claim under that policy. I just want to reiterate our conviction in the long term prospects of our Life Sciences business, which remains unchanged and we believe that ILSI Dover will play a key role in long term value creation.

Finally, we remain disciplined in our approach to M and A. And as a reminder, year to date, we have acquired 11 companies at a pre synergy multiple of 9.5 times. On the next slide, free cash flow for the second quarter was $210,000,000 which was down year over year due primarily to the timing of bond interest payments. Year to date free cash flow remains robust up 13% year over year. Total company liquidity is currently $3,900,000,000 underscoring the strength of our balance sheet and providing continued flexibility to pursue value creation opportunities in what remains a dynamic market environment.

Leverage for the quarter was 1.7 turns, which was a 0.3 turn improvement as compared to the prior year. And specifically within the quarter cash outflows included $500,000,000 deployed to share repurchases as well as $47,000,000 to M and A and $8,000,000 for our dividend payment. The $500,000,000 in share repurchases made during the second quarter represented approximately 6,100,000.0 shares at an average purchase price of $81.35 And as a reminder, we are still targeting up to an additional $250,000,000 of share repurchases for the balance of the year. I will now turn the call back to Vicente to discuss our segment results.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Thanks, Rick. On slide eight, second quarter orders for ITS finished up 7% year over year and up 5% sequentially from Q1 to Q2. Book to bill was 1.05 times. The segment delivered organic order growth in the low single digits making the second consecutive quarter of positive organic order growth. Revenue finished up low single digits.

Adjusted EBITDA margin declined year over year driven by the flow through on organic volume, the expected diluted impact from recently acquired businesses, the dilutive impact of tariff pricing matching tariff caused one for one and continued commercial investments for growth in the business. Moving to the product line highlights, compressor orders were up low single digits. Industrial vacuum and blowers orders were up high teens. And power tools and lifting orders saw a minimal decline of low single digits. On a regional view, we saw orders in Americas up high teens EMEA up high single digits and Asia Pacific up low double digits.

It is important to note that we saw organic order growth in China, which reflects the resilience of our team, the utilization of IRX and the effectiveness of our demand generation initiatives. In our innovation in action, the new Compare Ultima oil free compressor product is truly a breakthrough offering, delivering a 14% improvement in energy efficiency. This new compressor has an optimized design with a fully integrated air and drive that eliminates the need for a gearbox, reducing friction and increasing reliability and serviceability. Launched initially under the Compehr brand, this product exemplifies Ingersoll Rand’s multichannel, multi brand strategy as this technology will be launched on their other brands and across the globe. Turning to slide nine, Q2 orders in PSC were up 13% year over year with a book to bill of 0.96 times.

Important to note that for the first half of the year book to bill was above at 1.02 times. Organic orders were down 5%, but came in in large with expectations. In the prior year, we saw some larger long cycle orders, which were not expected to repeat in the current year. Excluding these large projects, organic orders were up low single digits. Revenue finished up 17% year over year, driven largely by M and A.

PST delivered adjusted EBITDA of $117,000,000 which was up 14% year over year with a margin of 29.5%. Adjusted EBITDA margins finished in line with expectations improving 40 basis points sequentially and are up 190 basis points over the past two quarters. For our PFT in action, we’re highlighting the EVO series electric diaphragm pump. This breakthrough technology sets a new benchmark delivering a 15% improvement in energy efficiency over previous technologies. It is also designed with an ergonomic single sided diaphragm for easier maintenance.

In addition, this product provides us with a perfect platform to launch the Aeroprotect, which is a care type solution similar to our offering on compressors, designed to maximize customer uptime and minimize costs while increasing recurring revenues. As we move to slide 10, we are raising our guidance on total revenue, adjusted EBITDA and adjusted EPS. As highlighted on the right hand side of the page, we’re increasing total revenue driven by M and A and FX, which is partially offset by a reduction in tariff related pricing. It is important to note that the change in organic revenue is solely based on a reduced tariff pricing assumption, which has no impact to adjusted EBITDA or adjusted EPS. Given that the tariff landscape will remain fluid due to the introduction of new trade agreements, we have included an appendix slide detailing our underlying assumptions incorporated into our latest guidance.

We have raised our adjusted EBITDA midpoint to 2,130,000,000 matching the top end of our previous guidance. We have also increased our adjusted EPS to $3.4 at the midpoint, which is up $06 or 2% from the midpoint of our previous guidance. For the rest of the component of our full year guidance, we anticipate our adjusted tax rate to be roughly 23%, net interest expense to be about $220,000,000 and CapEx to be around 2% of revenue. We have updated our share count assumption of approximately $4.00 3,000,000 shares, which reflects the impact of the $500,000,000 in share repurchases made during the second quarter. Our guidance excludes the effect of any additional share repurchases or M and A, which may happen later in the year.

At the bottom of the slide, we have added commentary regarding our own internal indicators we track, which continue to show positive signs. MQLs remain up double digits in the second quarter with continued momentum in July. Large long cycle funnel activity remains robust with approved projects continuing to progress through the decision making process. While the macro environment remains dynamic, business conditions remain stable and we’re encouraged by the organic order growth and robust book to bill we saw in the first half of the year. We continue to focus on controlling what we can control and our teams remain resilient and are executing very, very well.

We remain committed to leveraging our robust balance sheet to strategically deploy capital and drive value for our shareholders. Finally, on Slide 11, as we wrap up this portion of the call, I would like to highlight that we remain nimble and are prepared to pivot in what continues to be a dynamic global market environment. We will continue to utilize our strong balance sheet to strategically allocate capital, ensuring sustained durable value creation for our shareholders. Our capital allocation strategy remains unchanged and we will continue to be disciplined in our approach to M and A. To our employees, I want to thank you again for your part in delivering another strong quarter.

Remain focused on controlling what you can control and stay agile through the use of IRX. With that, I will turn the call back to the operator and open it for Q and

Conference Operator: A. Thank you. Your first question comes from Mike Halloran with Baird. Your line is open.

Mike Halloran, Analyst, Baird: Hey, good morning everyone. Good morning. Good morning Mike.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Hey, so maybe we can just talk a little bit about how you

Mike Halloran, Analyst, Baird: see the demand cadence, order cadence play out in the back half of the year. I know you saw sequential improvement, one q to two q. How did that track through the quarter and and and into the start of the third quarter? And what are you assuming guidance from a seasonality or improvement perspective, as we work through the back half of the year?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah, Mike. So, I mean, as you know, we don’t we don’t typically guide, orders externally. However, as we have, historically said, this is a business that tends to be around, you know, book to bill one on a full year basis. And, you know, we saw a pretty good start on the first half of the year with a book to bill of one point o six. So that kind of sets up well for for the second half in terms of the backlog that we have provided there.

You know, in the second quarter, in terms of continued momentum, we we actually saw a fairly stable continuation through the throughout the quarter. No no nothing to discern in terms of declines or but it was very consistent, as we have seen, you know, historically in a typical quarter. And that also continued, here in the month of July. So I would say that, that that kind of bodes well. You know, the second quarter, what we also saw is continued strength in the kind of the large long cycle orders, which was primarily the driver of the organic order growth, I’d say, here in the ITS side.

And we expect these orders to have a good impact here as we go into 2026 revenues. So kind of building up on that backlog already. But maybe the last point to highlight here in terms of Mike, in terms of the underlying demand, I mean, as we pointed out, ITS two quarters of positive order growth, which is good. And PST, if it wasn’t for the long cycle comp that it was really related to hydrogen orders last year, not this year, we will be kind of positive as well within the quarter.

Mike Halloran, Analyst, Baird: Thanks for that. And and

Vicente Reynal, Chairman and CEO, Ingersoll Rand: then maybe somewhat similar question on

Mike Halloran, Analyst, Baird: the margins. If look at what’s implied in the margins back half of year, a little bit of a step up, maybe just walk through the puts and takes, Why the step up in the back half of the year? Is it seasonal? Are there other factors associated with it?

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Yeah. Mike, this is Vic. I’ll take that one. So I think it would be fairly consistent with kind of how you’ve seen prior years. So just a couple of things to point out.

One, definitely seasonality. I think the cadence of revenue and earnings is very consistent in terms of our guide for 2025 is what you’ve seen historically. And so with the increased revenue profile in the back half of the year, you typically see some of the flow through come from that, not just on the organic volume and the pricing side, but then some of the productivity initiatives like i2b and things like that, that follow volume. The other thing I would say is the continued integration on the M and A side, whether it be the bolt ons as well as kind of as we’ve talked about for multiple quarters now, ongoing progress on the ILC Dover side. And it is worth noting that particularly in Q4 on a year over year basis, our PSC business probably has their easiest comp comparatively speaking, which obviously kind of helps factor into that.

So again, I would point to the normal kind of drivers and factors you would typically see that go along with seasonality.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Thanks, guys. Appreciate it. Thank you.

Conference Operator: The next question comes from Julian Mitchell with Barclays. Your line is open.

Julian Mitchell, Analyst, Barclays: Hi, good morning. Morning. Maybe just wanted to start with the sort of phasing within the second half of the sales and EBITDA step up that Vic just highlighted. I think historically, maybe just to start with, your EBITDA is about 26% of the year in Q3. So based on your full year guide, it’s a sort of $550 ish number for Q3.

Is that roughly the right way to think about it in terms of that Q3 for phasing?

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Yes, Julien, let me start with that. So obviously, we don’t provide quarterly guidance, but what I’ll say is this. First and foremost, I think the phasing of revenue and EBITDA is largely consistent with both our prior guidance and prior years. So we’ll start there. And then as you think about the back half of the year and kind of maybe to put a little bit of a finer point on the half, particularly as far as the moving parts.

First and foremost, we do expect obviously second half to be better than first half. But again, that’s very consistent with what we put out in our prior guidance. And I think the organic orders growth and book to bill that Vicente kind of referenced earlier through the first half of the year supports that view. As far as kind of the large moving parts, let me kind of break it down for you a little bit. In the second half of the year, we do expect organic volume growth to be down in the low single digit range, which compares to being down in the kind of mid single digit range in the first half of the year.

And on pricing, we expect pricing to be in the, let’s call it, 3.5% to 4% total range with a relatively even split between base pricing and tariff related pricing. And it’s worth noting that, that base price of about 2% is very much in line with what we’ve always indicated as a normal level of pricing that we should be able to generate in the business. And then on the margins, I think it’s exactly what you would expect. We do expect to see sequential margin improvement with Q4 kind of be in the high watermark for the year.

Julian Mitchell, Analyst, Barclays: That’s very helpful. Thank you. And when we’re thinking about the organic sales sort of year on year, total company, let’s say, I think the first half was down about 3.5% year on year. The full year guide is sort of minus 1%. So you’re up maybe low single digit in the second half year on year on organic sales at your guide midpoint.

Does all that growth come in the fourth quarter? Or do we see sort of flattish organic sales in Q3? And is that the same for both segments?

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Yes. Let me start there. I do think Q4 will be a little bit of a healthier growth than Q3. So Q3 slightly positive, Q4 slightly a little bit better than that is kind of the way the ramp will work between Q3 and Q4. The way that you outlined, obviously, the first half and the second half expectations is largely correct and consistent with kind of what I said before.

And then your second part of your question in terms of the two segments, what I would say is not dramatically different between the two segments. I think you’ve seen fairly consistent performance in terms of the volume side of the equation in the first half for ITS and PST. I don’t think you’re going see dramatically diverging performance between the two segments in the

Jeff Sprague, Analyst, Vertical Research: back half of the year.

Julian Mitchell, Analyst, Barclays: Great. Thank you.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Thank you.

Conference Operator: The next question comes from Jeff Sprague with Vertical Research. Your line is open.

Rob Wertheimer, Analyst, Melius Research: Hey. Thanks. Good morning, everyone.

Jeff Sprague, Analyst, Vertical Research: Hey, Jack.

Rob Wertheimer, Analyst, Melius Research: Appreciate you hit it. Hey. Good morning. Appreciate you hitting the ILC right up front. But we just talk about sort of dealing with m and a over time.

Right? These, you know, these bolt ons are you know, they look like they’re always sort of a layup and you wanna do as many as you can. I think they make sense. I would think as the company gets bigger, right, you and the targets potentially get bigger. There’s always gonna be things that maybe have some interest, but, you know, twenty, twenty five, 30% of sales might be something you didn’t really want that came along for the ride similar with what happened with ILC.

So maybe just a little bit more color on, you know, what you did to protect yourself. You know, you’ve mentioned some indemnities indemnities or something along those lines. And how do you think about, like, managing kind of, you know, potentially larger, more complex m and a down the road?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah. Jeff, no. Good question. I I, you know, a couple of things to note. Even even going to the ILC, you know, despite everything that that that you hear, you know, we still, are very enthusiastic with the life science, side of the business, which I again, it was 7575% of the portion of the business.

In totality, the ILC Dover, we expect to still be at mid single digit ROIC by year three. So which we view for this kind of large transaction to be actually not that not bad. Clearly, on the bolt on, as you said, we can get to mid teens ROIC by year three. We always expected that, you know, larger transactions will be less than that. And and and this is providing us the platform for the life sciences that that we have spoken about in the in the past.

And now as we continue with our playbook, you know, you make this kind of larger anchor of a of a platform and start bolting on at the same rate and kind of multiple multiples that you we have seen historically done with bolt ons and and that, you know, leads fluid as we announced that. And we have another one here in the in in the LOI that we expect to close pretty soon here over the next few days that it will be fairly similar in nature to kind of what we see here historically. Again, mid teens ROIC and bolt on. In in terms of how how we do large transactions, I mean, think about two as well when we combine Gardner Denver and Ingersoll Rand. I mean, we leverage IRX for the integration pretty extensively.

And ever since then, you know, five years later, after seventy seventy more than 70 transactions, we we we definitely have done a lot of lessons learned, a lot of continuous improvement, a lot of Kaizen around how do we continue to improve, our methodology. So we do have a playbook. And part of that playbook and holistic approach includes not only the comprehensive diligence, but also, negotiated representations and warranties. And in these IOC Dover transactions, these reps and warranties were backed by insurance, And we have filed a claim under that policy. As you can imagine, I mean, things are complex.

We completed our internal investigation, which was pretty extensive. And we felt ready to file. Is not something I want to emphasize, this is also something not that is taking up management team away from running the business. And in parallel, we have continued to, specifically to ILC, to invest, as we have said in prior quarters, adding new team members, creating the P and Ls and running the playbook that we run post integration.

Rob Wertheimer, Analyst, Melius Research: Great. Thanks for that color. And then just on the on the m MQL specifically, anything in just the the nature of these longer cycle projects that stand out regionally, vertical market, you know, different different flavors, or is there kind of a consistent theme in what you’re seeing on the longer cycle side?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah. Jeff, let me let also say, you know, on the on the, above the NQL, kind of a little bit of color here, NQL is in the long cycle. So as we step back, mean, always said that demand generation, which is our kind of what we call our marketing generation engine, help with provide a point of two or of growth above the market. And that kind of demand generation is kind of what leads a lot to these NQLs. And you see that on the overall compressor performance or even China where we’re seeing some organic positive despite the market that is not growing, we attribute that to the efforts to instigate demand and find pockets of growth through these MQLs and demand generation activity.

Clearly, you have seen here in the past couple of quarters is definitely a little bit of uncertainty, large projects shifting and other macro factors that are masking the NQLs not converting factor and providing that and showing that into the organic growth overall picture here. But we feel continue to feel encouraged by the momentum we see in MQLs. It is real demand end market that we feel it will come over time convert to orders. And we’ll definitely continue to keep those customers in our funnel and we’re prepared to close those orders as they see the opportunities. In terms of then the long cycle, I’d say, fairly spread.

I mean, here in the second quarter, we saw a lot of good solid momentum in wastewater facilities. I mean, water and wastewater infrastructure, that’s why you saw our vacuum and blower business to continue to accelerate. And we continue to see some pretty good performance in terms of some of the some of the re showing, that we see, you know, whether countries like India that, that is accelerating their side of localization for supply chains.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Great. Thank you.

Conference Operator: The next question comes from Rob Wertheimer with Melius Research. Your line is open.

Mike Halloran, Analyst, Baird: Good morning and thanks for the discussion there. Mean, it’s a little bit related to what I was going to ask in the MQL arena where you’ve had a little while of, and it’s not unique to you, but delayed decision making projects and not making it completely through And I guess my question is, is the reason for that changed over time? There was politics a while ago. Is tariff resolution an unlock here?

Or do you hear more from customers around interest rates? Or any sense of what might really kind of unwind that? And if you would, don’t know if you can also characterize, you talked about those larger projects, but when you see hesitancy, is does it go all the way down to smaller stuff or do you have steady flow and then it’s it’s really just the the bigger things? Thanks.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah, Rod. So it is I would say, I’ll call that as being more of a tariff resolution. I mean, I think there’s continued movement of the tariff percentage number that we obviously see it ourselves. And and that’s creating a, you know, major reaction in terms of flows and the unpredictability and uncertainty of what that that creates. In in terms of, of of some of the, you know, I will also add, you know, this bill, the big, beautiful bill act as well, that created a holdout, for some projects too as well, as you can imagine, on renewable energy and things of that nature.

So, to the second question, Rob, in terms of kind of this long cycle, we continue to see the movement. I mean, definitely much slower than what we typically have seen in the past. And and the range, it it it kind of varies. I would say, it will be site not ready, you know, a bit of a change in in technical work and technical specs, kind of some tweaks in the technical spec that kind of go back to then having the EPC to redesign and kind of work with us as a team to redesign. But I think the good news here is that we continue to see that engagement.

It’s not cancellation of projects. It’s just basically a much slower move of these projects through the funnel due to, in that case, I’ll say, change in specs or overcapacity or EPC is not having the engineering resources to complete the project and put it into a purchase order.

Mike Halloran, Analyst, Baird: Got it. Perfect. Thank you.

Conference Operator: The next question comes from Andy Kaplowitz with Citigroup. Your line is open.

Andy Kaplowitz, Analyst, Citigroup: Good morning, everyone.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Morning, Andy.

Andy Kaplowitz, Analyst, Citigroup: Vicente, just on PST, can you give more color into your legacy Gardner Denver Medical business? Are you seeing any green shoots there into the business turning? And then selling back on PST, as you know, you haven’t seen sort of that mid single digit plus growth algorithm in a while here. I do think you’ve easier comps in the second half as you talked about, but can you talk about your confidence in acceleration of overall PST moving forward?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah. On that legacy Gardner Denver medical business, you know, I I I categorize it as we’re we’re we’re we’re seeing good momentum on what we call the fluid handling side of the business. This is a business that particularly plays well with personalization of cancer research in cancer medicine where we continue to see some pretty good momentum. And when you think about that, what we kind of put it on the slides, it’s the second consecutive quarter of organic revenue growth in the life sciences. Now naturally being organic, that speaks volumes to that.

That’s basically the legacy Gardner Denver business. So, again, another good growth. So you can see that that is turning and seeing some better flow. In terms of kind of your mid single digits for the PST, yes, I mean, categorize that as we called out, I mean, again, good orders growth in the first quarter. In this quarter, if it wasn’t because of some of these large projects and again, these are large projects that specifically we decided to kind of abandon the market in terms of hydrogen refueling stations and things of that nature that we decided that it was better not to continue to pursue that.

Then that that is the if you were to eliminate that, that puts us into positive, organic, order growth. And when you look and kind of peel the onion on this kind of what it was called the legacy PST or we call Precision Technology, that’s some of those pump businesses are so growth in that mid single digit from an order perspective. So again, that’s why we continue to feel good about there’s a turning point, an inflecting point, and we expect that, that continue to improve on a sequential basis.

Andy Kaplowitz, Analyst, Citigroup: Senator, that’s helpful. And then maybe this one’s for Vic. Maybe just a little more color into that IT and S margin in Q2 because I think you expect the margin to sequentially increase and it did decrease a bit. I know you called out all the factors that impacted margin, but were there any in particular that were slightly worse than you were expecting? Can you talk about your confidence level?

I know you’ve got improving margin dialed in for the second half.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Yes. So, Andy, I think just to kind of restate that we mentioned the factors with regards to the volume, some of the M and A and then kind of the dilutive impact on the tariff pricing offsetting costs one for one. Was there anything that I would say was tremendously out of sorts, out of efficient? No, I wouldn’t point to anything of a dramatic nature. Again, this is a business that’s still playing that 29%, roughly speaking, EBITDA margin profile.

So extremely healthy and one that we quite frankly kept up in that 29 level despite some of the volume headwinds that we’ve called out. So I do think that we expect to see sequential margin expansion as we stated in the kind of the earlier question kind of in line with kind of normal what I would call seasonality. But again, nothing I would say out of sorts or anything that we think caused any concern or anything of that nature that we saw in Q2.

Andy Kaplowitz, Analyst, Citigroup: Appreciate the color.

Conference Operator: The next question comes from Nigel Coe with Wolfe Research. Your line is open.

Nigel Coe, Analyst, Wolfe Research: Thanks. Good morning, So just wanted to just want to make sure I’ve got the right numbers. So price, I think you said, Vic, 3.54% in the back half of the year. So I’m just wondering, is that equally distributed across the portfolio? So I think we hear about more about ITS.

Are we seeing that in services and equipment? And are we seeing that globally? Or is this more concentrated in U. S. Equipment?

So therefore, U. S. Compressors will be up closer to 10%. Just any color there would be helpful.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Yes. So let me maybe start at the top of the house and I’ll maybe work my way down, Nigel. One, I think that expectation of 3.5 to 4%, I think, is actually fairly comparable between the two segments. And like we said, a relatively equitable split between or even split between what I’ll call base pricing, which as you would expect has the typical flow that you would expect and then the tariff related pricing, which is essentially offsetting tariffs one for one. Now as far as the second part of your question, as far as the regional splits, I would say that when you think about ITS, I would say it is pretty well equitably spread and split with maybe the exception of China is obviously a bit of a tighter pricing environment comparatively speaking, which is probably as expected.

But I think when you think about Europe, North America, Latin America, even the power tools business, I think we’re generating the equitable price you would expect. And yes, it is, I’d say, comparable between the components, I. E, the compressors and or the aftermarket of the service. We don’t take what I would call a peanut butter approach to pricing. It’s very targeted.

I would say that’s even been the case where we’ve had to take certain tariff related actions. So again, it’s very consistent, I think, with the pricing kind of strategy you’ve seen us do historically. Maybe the only nuance here is that tariff related pricing, which is, I’d say, just offsetting costs one for one.

Nigel Coe, Analyst, Wolfe Research: Okay. That’s great color. Thanks. And then maybe just following up on Rob’s question around what sort of unlocks this next investment cycle. Because I think the way you sort of framed the second half volumes down low single digits was conservatism back in April.

Now we sort of hardwired that. It feels like we’ve got better visibility with tariffs, etcetera. So just wondering, are we seeing like sort of a step down here and another step down in the market? Are we seeing a push out in decisions? So I guess the question is, what’s changed versus April in terms of that sort of conservatism view?

And what do you think percentage kind of unlocks this demand cycle?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yes. No, I Nigel, good question. I mean, what we decided to do here in the guidance is continue to be on the precautionary side as we think about the volume side. And and that is obviously, today, there’s a deadline in a lot of the tariffs. So we see some of the outcome of that.

But we we we you know, I think a lot of that clarity will will definitely unlock, what we consider a lot of the conversations that we’re having with many customers that they’re just saying, hey. We we’ve been holding on for a little while. What is it? Waiting waiting a few more weeks or a few more months to kinda complete this, holistic picture. So I I we do think that based on a lot of the conversations, whether it is the tax incentives, depreciation in The U.

S. And clarity of that or if you go to Asia Pacific or countries outside of China, customers kind of waiting to see, I mean, South Korea, good to see the outcome of that tariff and Japan. So a lot of that clarity is going to start driving the decision and the unlocking of what we’re seeing in our funnels. That’s our view. But right now, we decided to continue to be precautionary.

Okay. Thanks. Thanks.

Conference Operator: The next question comes from Joe Ritchie with Goldman Sachs. Your line is open.

Joe Ritchie, Analyst, Goldman Sachs: Hey, guys. Good morning.

Andy Kaplowitz, Analyst, Citigroup: Good morning, Hey,

Joe Ritchie, Analyst, Goldman Sachs: thanks for the initial comments on ILC, Joe. I just want to I just want to be clear, I guess, maybe around one one specific item. So so the customer that you referred to, I know you don’t wanna call it out by name, but is it consistent with the, you know, reduction in guidance, the revenue guide that you that you saw a year ago when when the transaction had just closed? Or is this the new customer that we’re talking about within the aerospace and defense sector?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: So Joe. This is a this is a new customer, customer of the project that is really tied to the next generation, International Space Station and which has been delayed. I mean, the funding for this seems to be kind of having approved already in the big beautiful bill, but it’s kind of just getting delayed. So that’s what that’s that’s basically the decline.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Yeah. Joe, the only thing I’d add to that, though, is as you saw in our guidance, though, you know, there’s really no change to the organic equation other than tariff pricing. So I think, you know, the team has done a nice job to kind of supplement and offset that that volume. So that’s, again, why you’re not seeing any, you know, short term change to the to the to the current guide.

Joe Ritchie, Analyst, Goldman Sachs: Okay. Got it. No. Appreciate the clarification there. And then I know we’ve had some some discussions around, the marketing qualified leads and then ultimately that turning into better organic growth.

I guess when I when I take a look at maybe just the compressor business or ITS just the last couple years, the the the order growth has been fairly muted. And so, you know, I know we’re getting we’re starting to get some questions from investors, like, whether, yeah, structurally, there’s any concerns around maybe the longer term growth algorithm for compressors going forward. So, you know, Vesethe, maybe you can kinda tackle that question head on and how you feel about the long term, you know, kinda growth, opportunity within compressors and and and why maybe we’ve seen a little bit more muted growth, over the last two years.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah. Joe, the the the long term absolutely does not change. And and if anything else, we continue to get more excited because, obviously, as as we go and attach a lot of these solutions for recurring revenue, that that provides, in our view, you know, even better upside than what we even consider originally when we were looking at a lot of this back in the Gardner Denver days. I think what you have seen here over the past couple of years is that there’s definitely been a lot of kind of fluctuation of large projects or large kind of onetime investments, whether renewable natural gas in The U. S.

That turned to be almost $100,000,000 of revenue that then next year turns to basically, call it, down to 10,000,000 to 20,000,000 So I think when you peel the onion and take a lot of those projects and look at fundamentally the base of what we’re seeing in the compressor market, we continue to see pretty I mean, I’ll say positive stable growth comparable to what we call historically as that GDP plus. And then on top of that, we try to overcome that. So I think it feels like over the past couple of years, we have seen obviously a more normalization of these large compressors. And now we’re seeing like China as an example, again, one month is not a trend, but China as an example, we’re now after all that kind of large investments in projects such as electric vehicle, battery production and things of that nature. Now we’re getting into much of that normalcy.

And China, hey, market is not growing, but our team in China saw positive order organic growth here in the second quarter. We’re not predicting that China is going to continue to be accelerating. But again, we continue to expect that we take some share. So no fundamental change in the growth algorithm. I think as we can see more normalization here, x large projects, things will be more stable.

Jeff Sprague, Analyst, Vertical Research: Thank you.

Conference Operator: The next question comes from Chris Snyder with Morgan Stanley. Your line is open.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand0: Thank you. So I understand that the organic guide down is just a function of less tariff related price. But last quarter, it seems like a portion of the volume cut was just a function of this higher price coming through, which brings, you know, elasticity concerns. So I guess now that we have, you know, price coming in a little bit lower, but no positive volume response from that, Like, do you think that’s an indication that underlying demand is softening as we’ve gone through the year?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah. Chris, this is Vivek.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: I’ll take that. So I think like we said when we when we gave the guidance framework a quarter ago, we said we’re taking a precautionary view of the year given the uncertainty. And I think the simple way to think about that is we just haven’t changed that view as we kind of think about the equation. And that’s what you see in the framework from a guidance perspective. Now to Vicente’s point that was kind of just made, as we hopefully get a little bit more certainty on where tariffs land and things like that, with some of the things from the bill and things of that nature, those should hopefully be tailwinds in the grand scheme of the equation.

And unless to the degree that the volume equation is a little bit healthier than what our guidance applies, we’ll consider that maybe the upside of the framework we put forth. But I think we just saw it prudent to keep the, you know, the precautionary kind of outlook that we had before. And that’s kind of, I think, you know, what you should see from the guidance framework. Nothing nothing nothing more than that.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand0: Thank you. Very much appreciate that. I guess, you know, has there been any change in sentiment from international customers following the tariffs? And I guess if we look at the overall company orders flattish, is there anything you could provide on on the regional splits there? Thank you.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah. Sure, Chris. I I I I’ll I’ll say that, you know, from a regional perspective, you know, we saw we saw positive orders organically, even in EMEA, Europe, Middle East, and India. So, again, you know, if I if I were to think about this holistically, I’ll say Asia Pacific, you know, what I what we called out, China, positive organically. I’ll say the rest rest of the countries, maybe a little bit of more kind of waiting.

These customers are waiting for better clarification of the tariff agreements. I’ll call out EMEA as being fairly resilient. As I just said, Latin America remains very healthy and encouraged by the results that we’re driving with the investments that we continue to make. And North America, sluggish, I mean, in the second quarter, given all the uncertainty around tariffs. So we remain but we remain very cautious, optimistic about the medium term here in North America.

So long cycle, continue to see strong momentum in longer cycle, which helps build that backlog for 2026.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand0: Thank you. I appreciate that.

Conference Operator: The next question comes from Joe O’Dea with Wells Fargo. Your line is open.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand1: Hi, good morning. I wanted to start just on back half bridge and when we think about some of the key drivers And so the volume assumption moving to down low single from first half of the year down mid single, that seems like it’s really comps. And so there’s no kind of underlying assumption in volume sequentially being much better. And then on the EBITDA side, pricecost seems like it would be the most important driver. Is that pricing in place such that there is a notable step up from 2Q to Q3?

Or is there still pricing that you plan to implement in the back half of the year?

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Yes, Joe, this is Ike. Let me take that one. So I think the way you framed it out on the volume side is fairly I’d say it’s a pretty good assessment. But I do think it’s worth noting that with the positive organic orders, particularly in the ITS side that we’ve seen in the first half and the book to bill, that does give us more conviction in that slight improvement on the organic volume side you see from the first half to the second half. As far as your price cost equation, yes.

And I think simply stated here, those pricing actions have essentially they’re in place, have been taken. We obviously are tracking and monitoring that, and I I think we have, you know, good good visibility to that kind of already being in place. So, I think the simple answer to your question is, yeah, I think you’ve you’ve framed it up fairly nicely, and that’s kind of, you know, I think one of the drivers of the back half margin expansion. Not the only one. Like I said, some of the seasonality and volume and some of the productivity factors that come in as well as some of the ongoing integration of some of the bolt on M and A, including some of the ones we just announced here today.

But yes, I think you framed it out quite nicely.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand1: And then on the clean energy vertical in ITS, can you unpack that a little bit? Just talk about what you’re seeing in terms of demand trends, some of the end markets, kind of regional activity, just overall kind of what you’re watching there for the opportunity set?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yes, Joe, if I take it by region, I think here in The U. S, what and I made a comment about that, about renewable natural gas. We’re seeing stagnation there. Whereas we saw prior couple years ago, I mean, some very good resurgence and acceleration due to the IRA implementation. We we we’re seeing, you know, really slow down now.

So, again, that that continues to be the case. You know, if you, go to then, Europe I I think Europe, in terms of, biogas and RNG production that continues to be, I’d say, good investments and good momentum there. And then when you go to even Asia Pacific, in particular China, anything related to kind of fuel gas booster application for power gen, also pumping storage for hydropower, things of that nature are seeing some really acceleration in the China side. So again, what we’re seeing is definitely this kind of mix of different end markets based on where the regions that we’re co located. Again, and last one will be Latin America, good investments that we’re seeing clean energy.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand1: Great. Thank you.

Conference Operator: The next question comes from Nathan Jones of Stifel. Your line is open.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand2: Good morning, everyone.

Andy Kaplowitz, Analyst, Citigroup: Good morning, Nathan. I just wanted to

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand2: ask I wanted to just ask a follow-up on the building of the platform for life sciences here. Your lead flow is obviously pretty small, and it’ll take some time to to build out a life sciences platform at that pace. Any kind of color you can give us on, you know, if there are larger bolt ons out there that that you could use to build that more rapidly? Do you think you need to deploy more capital into that to build scale? Just any color you can give us around the strategic pathway to building that business out.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Sure. No. No. I I I mean, not not not at this point, I will say. And and keep in mind that, you know, we we like to be more into kind of more niche applications and niche specific steps within the process.

So, and that’s that was basically how it’s over. I mean, see it over great play into the GLP one and the and the power containment and ADC, high potency a APIs that kind of co locate to immunotherapies in the future grand scheme of things. Same thing with lit lit fluid. Mean, lit fluid, very highly great technology in perstalptic pump technology. Then now we can leverage not only in Asia but globally.

And these that we have in LOI that will close again small bolt on, but provides a very niche application that is highly, highly complementary with what we do in ILC and how we sell to customers. So that’s the path. I mean, path will continue to be in these kind of very niche applications that where we can command great share, and that will lead into good price, great margin, and, and our ability to to be more closely to the customer.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand2: I guess, one on, the accelerated depreciation that’s in, the BBB. It’s probably unfair to ask, you know, if you think that’ll be a catalyst for four q spending, but we have had periods historically where we’ve had accelerated depreciation. Maybe you could just comment on what historically you’ve seen that in terms of it being a catalyst for maybe late year spending to take advantage of those kinds of things?

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Yeah. Nathan, I’ll I’ll take that one. I’ll keep it pretty simple. You’re right. Kind of hard to prognosticate what that may or may not mean.

I I think, you know, we view it as as definitely a, you know, a bit of a tailwind, you know, a good positive factor. You know, obviously, we hope to see it kind of drive some degree of acceleration in second half orders, but I don’t think that our guide or the framework we put forth contemplates that. Right? So historically, maybe some movement there, but nothing that I would consider to be an extreme needle mover comparatively speaking.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand2: Great. Thanks for taking the questions.

Conference Operator: The next question is from Nicole DeBlase with Deutsche Bank. Your line is open.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand3: Yes. Thanks for squeezing me in guys. Good morning.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Good morning.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand3: Maybe just starting with the power tools and lifting business. I think the orders here got a bit worse, turned negative again. Can you give a little bit more color on what you’re seeing there? That’s been a business that’s been kind of tough from an order perspective for a while now. Do you think that we’re getting close to a bottom there?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah. Because I I you know, I think q one, we said that orders were actually positive in q one as I recall. Yeah. I mean, I I I would say, nothing of significant color that that that I would call as being, you know, negative. You know, we’re we’re seeing you know, we have in this business inside the business, there’s a couple of different businesses, one around material handling that continues to actually do fairly well.

And, and and we’re very positive with what we’re seeing here on the power tool side as we’re launching new, new products into the market. And so nothing of significant. Again, it’s a business that we continue to invest. We see as you see, I mean, margins are pretty close to the fleet average and generates good cash.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand3: Got it. Thanks, Vicente. And then just as a follow-up, I know you guys said that you wouldn’t give guidance on second half orders, totally understand that. But if you kind of do the math on normal seasonality, which is what you have said, you do kind of get to like an organic order decline in the third quarter, I believe, unless my math is wrong. Would you guys push back to that?

Just curious on your perspective.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Yes, Nicole, like we said, we’re not going try to guide on orders or anything like that. I think probably the best way to answer this is kind of how Vicente kind of framed up July. I think MQL momentum and kind of what we’re seeing has been continue to move at a comparable pace as what you saw in Q2. And you obviously saw the order performance there. And we spoke about the drivers between the two segments.

So again, nothing that we’re seeing that’s anything dramatically different, changing trends, things like that. And listen, this is still kind of in the wake of, I would say, the uncertainty around tariffs, as we mentioned here. So hopefully, as certainty gets a little bit more bit more certainty on the tariff front, hopefully, that’s something that can drive a little bit more certainty and acceleration. But again, nothing I would say that today we’re seeing that’s anything dramatically different is what we saw exiting Q2.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand3: Understood. Thank you, Vic. I’ll pass it on.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Thank you, Nicole.

Conference Operator: The next question comes from Andrew Buscaglia with BNP Paribas. Your line is open.

Jeff Sprague, Analyst, Vertical Research: Hey, good morning everyone.

Mike Halloran, Analyst, Baird: Good morning, Andrew.

Jeff Sprague, Analyst, Vertical Research: Just wanted to check on capital allocation. Just it sounds like you have some M and A still in the pipeline per usual, but what’s your preference maybe for share repo over the near term? How are you thinking about that?

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand: Yeah. Andrew, I’ll keep it pretty simple here. I don’t think anything’s changed from our kind of capital allocation strategy. Yes, you did see, some accelerated share repurchase activity in Q2, up to $500,000,000 We have said that we’ll do up to about $250,000,000 more for the balance of the year. But without question, the focal point of the capital allocation strategy sitting here today as well as even moving into future years will continue to be the M and A led by the bolt on strategy, as Vicente mentioned.

So again, nothing has really changed, and we’ll continue to execute on share repurchase very much in line with what you’ve kind of seen in prior years.

Jeff Sprague, Analyst, Vertical Research: Yes. Okay. And then maybe just to check, your aftermarket expansion has been solid. What what how do you foresee the the year playing out or the next or the next couple years playing out? Maybe if we get a release on some decision making in the capital equipment side.

I guess yeah. I guess, what are the how how are the dynamics how the dynamics feel to you on on that kind of mix?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah. No. I I think we we we have always said that we want to continue to accelerate the growth on the aftermarket, and particularly, that’s why the recurring revenue is is a very, very important step and initiative on that. We we want that that, you know, percentage to continue to grow. Even if the whole goods or new equipment gets, you know, unlocked and released and grow, we want to continue to outgrow that so that that percentage continues to be a bigger piece of the total equation.

Jeff Sprague, Analyst, Vertical Research: Got it. Thank you.

Conference Operator: The next question comes from Amit Mehrotra with UBS. Your line is open.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Thanks. I’ll keep it quick

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand4: here. We’ve obviously we’ve observed pharma companies kind of announce pretty meaningful US production capacity increases. I think we’re tracking something like 300,000,000,000 over the next, you know, four or five years. None of those have been constructed yet. So maybe it’s too early, but can you just talk about, you know, the opportunity that offers you given, obviously, the exposure to that vertical?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah. I mean, a great question. I mean, this is this is why we continue to be, you know, I guess, optimistic about the the what we call this long cycle. I mean, that that would typically based on the size of some scope of those projects, it will fall into that, not only in the compressor side, but then even also as you think from an IOC perspective. Because, I mean, some of that expansion happens with some of our customers that, that are currently buying our products, today.

And, obviously, that that would help, even more so. So, yeah, it’s it’s an area that, we’re staying pretty close pretty close with the EPCs that that are doing it, with the construction firms, and then also clearly very close to the customer. And and and is is any of that

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand4: I mean, obviously, when I look at the first half book to bill, typically, it’s sub one and then it’s above one in the back half. But obviously, you outperformed that in the first half. Is any of that in the book to bill? And And do you still expect the normal seasonality of book to bill being above one in the second half to continue?

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Yeah. No. So we’re I mean, early to see a lot of that. Mean, as you can imagine, this project get the project gets announced, and it takes it takes a while to get going. But but no no improvement.

I mean, I as it is right now, we’re saying, you know, book to bill of roughly one for the entire year, as I said. And, that means, you know, maybe above one as we sold out, but that means that it will be less than one. That’s kind of what we see in terms of the seasonality, and nothing that we change changes our mind right now as we continue to be precautionary in this environment.

Matthew Ford, Vice President, Investor Relations, Ingersoll Rand4: Got it. Okay. Thank you

Vicente Reynal, Chairman and CEO, Ingersoll Rand: very much. Appreciate it. Thank you, Amit.

Conference Operator: That is all the time we have for questions. I’ll turn the call to Vincente for closing remarks.

Vicente Reynal, Chairman and CEO, Ingersoll Rand: Thank you, Sarah. I appreciate the level of interest in Ingersoll Rand. Thank you for all the great questions, and thank you to employees that are listening to the call. And let’s just, keep staying focused and controlling what you can control. Thank you, everyone.

Conference Operator: This concludes today’s conference call. Thank you for joining. You may now disconnect.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.